Kaken Pharmaceutical Statistics
Total Valuation
KKPCF has a market cap or net worth of 1.04 billion. The enterprise value is 768.49 million.
| Market Cap | 1.04B |
| Enterprise Value | 768.49M |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
| Current Share Class | 37.87M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 5.01% |
| Owned by Institutions (%) | 28.62% |
| Float | 32.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.16 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -31.44 |
| EV / Sales | 1.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.09, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.09 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -93.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.86% |
| Return on Capital Employed (ROCE) | -2.51% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | 428,575 |
| Profits Per Employee | -21,706 |
| Employee Count | 1,126 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.91M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.69% in the last 52 weeks. The beta is 0.07, so KKPCF's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -4.69% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.80 |
| Average Volume (20 Days) | 429 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KKPCF had revenue of 482.58 million and -24.44 million in losses. Loss per share was -0.64.
| Revenue | 482.58M |
| Gross Profit | 256.22M |
| Operating Income | -24.43M |
| Pretax Income | -29.35M |
| Net Income | -24.44M |
| EBITDA | -9.10M |
| EBIT | -24.43M |
| Loss Per Share | -0.64 |
Balance Sheet
The company has 292.36 million in cash and 24.56 million in debt, with a net cash position of 267.80 million.
| Cash & Cash Equivalents | 292.36M |
| Total Debt | 24.56M |
| Net Cash | 267.80M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 929.97M |
| Book Value Per Share | 24.56 |
| Working Capital | 465.04M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -5.06% |
| Pretax Margin | -6.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.26, which amounts to a dividend yield of 4.70%.
| Dividend Per Share | 1.26 |
| Dividend Yield | 4.70% |
| Dividend Growth (YoY) | -3.49% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 4.80% |
| Earnings Yield | -2.34% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |